David Cameron

14PUBLICATIONS
177CO-AUTHORS
Phylogeny and comparative analysisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 12, 2026
Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

|Dec 22, 2025
Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Chiara Biagioni, Danai Fimereli, Alexandre Irrthum

|Oct 08, 2025
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

Shanu Modi, William Jacot, Hiroji Iwata

|Oct 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis.

Per Karlsson, Anthony Fyles, S Laura Chang

|Feb 01, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Patricia A Ganz, Hanna Bandos, Tanja Španić

|Nov 08, 2023
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7.

Aleix Prat, Nadia Solovieff, Fabrice André

Pageof 3

Frequent Collaborators

3 joint publications

Richard Gelber

3 joint publications

Martine Piccart

2 joint publications

Sylvie Giacchetti

2 joint publications

Andreas Schneeweiss